Cargando…
Mobilization-based chemotherapy-free engraftment of gene-edited human hematopoietic stem cells
Hematopoietic stem/progenitor cell gene therapy (HSPC-GT) is proving successful to treat several genetic diseases. HSPCs are mobilized, harvested, genetically corrected ex vivo, and infused, after the administration of toxic myeloablative conditioning to deplete the bone marrow (BM) for the modified...
Autores principales: | Omer-Javed, Attya, Pedrazzani, Gabriele, Albano, Luisa, Ghaus, Sherash, Latroche, Claire, Manzi, Maura, Ferrari, Samuele, Fiumara, Martina, Jacob, Aurelien, Vavassori, Valentina, Nonis, Alessandro, Canarutto, Daniele, Naldini, Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240327/ https://www.ncbi.nlm.nih.gov/pubmed/35617958 http://dx.doi.org/10.1016/j.cell.2022.04.039 |
Ejemplares similares
-
Mobilization-based engraftment of haematopoietic stem cells: a new perspective for chemotherapy-free gene therapy and transplantation
por: Canarutto, Daniele, et al.
Publicado: (2023) -
Gene Editing of Hematopoietic Stem Cells: Hopes and Hurdles Toward Clinical Translation
por: Ferrari, Samuele, et al.
Publicado: (2021) -
P1373: UNCOVERING UPSIDES AND PITFALLS OF BASE AND PRIME EDITING IN HEMATOPOIETIC STEM CELLS
por: Fiumara, Martina, et al.
Publicado: (2023) -
Efficient gene editing of human long-term hematopoietic stem cells validated by clonal tracking
por: Ferrari, Samuele, et al.
Publicado: (2020) -
Lipid nanoparticles allow efficient and harmless ex vivo gene editing of human hematopoietic cells
por: Vavassori, Valentina, et al.
Publicado: (2023)